Headshot of Susan Zelasko

Undergraduate education

University of Illinois – Urbana/Champaign - BS (2015)

Years in MSTP

2017-

Research interest

Human microbial symbionts as a source of bioactive molecules to be used for antibiotic drug development

Undergraduate/master's publications

R Arnold W, Zelasko S, D Meling D, Sam K, Das A. Polymorphisms of CYP2C8 Alter First-Electron Transfer Kinetics and Increase Catalytic Uncoupling. Int J Mol Sci. 2019 Sep 18;20(18). pii: E4626. PMID: 31540428.

Rabe JL, Gardner L, Hunter R, Fonseca JA, Dougan J, Gearheart CM, Leibowitz MS, Lee-Miller C, Baturin D, Fosmire SP, Zelasko SE, Jones CL, Slansky JE, Rupji M, Dwivedi B, Henry CJ, Porter CC. IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia Progression. Cancer Res. 2019 Jul 15;79(14):3702-3713. Epub 2019 May 29. PMID: 31142509.

Meling DD, Zelasko S, Kambalyal A, Roy J, Das A. Functional role of the conserved i-helix residue I346 in CYP5A1-Nanodiscs. Biophys Chem. 2015 May-Jun;200-201:34-40. PMID: 25900452.

Zelasko S, Arnold WR, Das A. Endocannabinoid metabolism by cytochrome P450 monooxygenases. Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:112-23. Review. PMID: 25461979.

Zelasko S, Palaria A, Das A. Optimizations to achieve high-level expression of cytochrome P450 proteins using Escherichia coli expression systems. Protein Expr Purif. 2013 Nov;92(1):77-87. PMID: 23973802.

Zelasko S, Gorski A, Dabrowska K. Delivering phage therapy per os: benefits and barriers. Expert Rev Anti Infect Ther. 2017 Feb;15(2):167-179. PMID: 27885865.